LATEST NEWS
- Videos
 
					Hear from Deputy Director of Advancement Kelsey Dale about the La Jolla Institute’s Tullie and Rickey Families SPARK Awards program.
				
				- In the News
 
					After infection or vaccination immunity to the virus may be long lasting
				
				- Institute News
 
					LJI Professors Shane Crotty, Ph.D., Bjoern Peters, Ph.D., and Alessandro Sette, Dr. Biol. Sci., were named “Highly Cited Researchers” this week by Clarivate. 				
				- In the News
 
					A year of scientific uncertainty is over. Two vaccines look like they will work, and more should follow.
				
				- In the News
 
					Blood samples from recovered patients suggest a powerful, long-lasting immune response, researchers reported.				
				- In the News
 
					Immunity to the novel coronavirus may last eight months or longer, according to a new study authored by respected scientists at leading labs, which found that individuals who recovered from the coronavirus developed “robust” levels of B cells and T cells (necessary for fighting off the virus) and “these cells may persist in the body for a very, very long time.”				
				- Research News
 
					LJI study suggests future asthma therapies need to target two key immune molecules				
				- In the News
 
					San Diego scientists and trial participants are cautiously optimistic after early reports that Pfizer’s COVID-19 vaccine is highly effective
				
				- Research News
 
					Stopping emerging viruses could depend on getting T cells and antibodies to work together				
				- Institute News
 
					New research could shed light on how immune cells can better fight cancers or step back in autoimmune disease				
				- In the News
 
					The body’s immune system is immensely intricate. A new study released in the UK is causing a stir because of what it says about possible limits to our immunity to COVID-19. Dr. Alessandro Sette talks with The World’s Marco Werman about what the study’s results mean for the possibility of a strong coronavirus vaccine.				
				- Institute News
 
					New immune cell studies may shed light on heart attacks, inflammation seen in COVID-19 patients